| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/13/2013 | EP2566970A1 Use of a genetically modified cell line expressing functional asialoglycoprotein receptor in the production of sialylated glycoproteins |
| 03/13/2013 | EP2566890A2 Anti-pai-1 antibodies and methods of use thereof |
| 03/13/2013 | EP1392359B2 Specific binding proteins and uses thereof |
| 03/13/2013 | CN1606618B Novel alkali protease formed by bacillus gibsonii (DSM 14393) and washing and cleaning agents containing said novel alkali protease |
| 03/13/2013 | CN102971342A Novel lowered affinity antibodies and methods of marking the same |
| 03/13/2013 | CN102965424A Preparation method of highly emulsified soybean protein |
| 03/13/2013 | CN102965423A Preparation method of silk fibroin peptide with bacteriostatic activity |
| 03/13/2013 | CN102965422A Method for extracting oil camellia protein from camellia seed cake |
| 03/13/2013 | CN102965421A Preparation method and application of bioactive peptides for promoting yeast growth and improving ethanol tolerance performance of yeast |
| 03/13/2013 | CN102965420A Method for producing polypeptide antibiotics nosiheptide through fermentation |
| 03/13/2013 | CN102965419A Fermentation optimization technology of recombinant human growth hormone engineering bacteria |
| 03/13/2013 | CN102965418A Extraction method for biological oat polypeptide and applications thereof |
| 03/13/2013 | CN102965390A Fermentation production method for antibacterial peptide LP gene transformed yeasts |
| 03/13/2013 | CN102965316A Feed additive, premix and mixture containing like-bacteriocin and pediococcus acidilactici |
| 03/13/2013 | CN102964427A Bioactive polypeptide QEPVL, and preparation and application thereof |
| 03/13/2013 | CN102961740A Preparation method of diphtheria toxoid vaccine |
| 03/13/2013 | CN102961733A Application of seaweed polypeptide in preparing health-care product for reducing blood fat and blood sugar as well as beverage containing polypeptide for reducing blood fat and blood sugar |
| 03/13/2013 | CN102961298A Manufacturing method of body lotion by taking Pullulan polysaccharide and sericin bioactive peptide as main raw materials |
| 03/13/2013 | CN102363798B Preparation process for collagen sponge |
| 03/13/2013 | CN102154423B Method for preparing active peptide of laver |
| 03/13/2013 | CN102127531B Korean novel duck hepatitis viral antibody ELISA (Enzyme-Linked Immunosorbent Assay) detection kit |
| 03/13/2013 | CN102093993B Kringle 5 mutant protein, and preparation method and application thereof |
| 03/13/2013 | CN101928723B Preparation of new apolipoprotein A-II |
| 03/13/2013 | CN101928722B New preparation of apolipoprotein A-IV |
| 03/13/2013 | CN101928721B Preparation of new apolipoprotein C-I |
| 03/13/2013 | CN101845472B Method for preparing scale collagen antioxidant peptides by using no-feed supplement enzymolysis-membrane separation coupling technology |
| 03/13/2013 | CN101134779B Antibodies specific for human CD22 and their therapeutic and diagnostic uses |
| 03/12/2013 | US8394942 Nucleic acid encoding a silk protein and a method of producing a silk thread using same |
| 03/12/2013 | US8394938 Artificial entropic bristle domain sequences and their use in recombinant protein production |
| 03/12/2013 | US8394931 Anti-HMGA1 monoclonal antibodies, process for their preparation and their use for the quantitative determination of HMGA1 |
| 03/12/2013 | US8394929 Nogo receptor-mediated blockade of axonal growth |
| 03/12/2013 | US8394928 Humanized anti-CDCP1 antibodies |
| 03/12/2013 | US8394927 FGFR4 antibodies |
| 03/12/2013 | US8394926 Pharmaceutical compositions with resistance to soluble CEA |
| 03/12/2013 | US8394925 Fc variants with altered binding to FcRn |
| 03/12/2013 | US8394924 Directed engagement of activating Fc receptors |
| 03/12/2013 | US8394771 Multimeric proteins and methods of making and using same |
| 03/12/2013 | US8394756 Methods of increasing RDCVF 1 or RDCVF 2 polypeptides in retinal cells |
| 03/12/2013 | US8394607 Anti-CD22 antibodies and immunoconjugates and methods of use |
| 03/12/2013 | US8394605 Genetically programmed expression of proteins containing the unnatural amino acid phenylselenocysteine |
| 03/12/2013 | US8394604 Protein splicing using short terminal split inteins |
| 03/12/2013 | US8394375 Antibodies for amyloid specific peptides |
| 03/12/2013 | US8394368 Method for producing a composition for promoting survival of transplanted hematopoietic stem cell |
| 03/12/2013 | CA2576953C Polypeptide having activity of unsaturating omega 3-fatty acid, polynucleotide coding for the polypeptide and use thereof |
| 03/12/2013 | CA2497744C Antibody against secreted n-terminal peptide of gpc3 present in blood or c-terminal peptide of gpc3 |
| 03/12/2013 | CA2479927C Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 03/12/2013 | CA2468888C Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof |
| 03/12/2013 | CA2407910C Antibodies that immunospecifically bind to blys |
| 03/12/2013 | CA2288218C Novel differentiation-inhibitor |
| 03/08/2013 | CA2845395A1 Antibody against colorectal cancer marker |
| 03/07/2013 | WO2013033456A2 Microbial nanowires and methods of making and using |
| 03/07/2013 | WO2013031821A1 Protein production method using transformed plant cells |
| 03/07/2013 | WO2013031734A1 Transgenic bird expressing foreign gene using endoplasmic reticulum chaperone promoter |
| 03/07/2013 | WO2013030329A1 Protein expression |
| 03/07/2013 | WO2013009648A3 Cell culture process |
| 03/07/2013 | US20130060011 Fc-free antibodies comprising two fab fragments and methods of use |
| 03/07/2013 | US20130060009 Process for obtaining antibodies |
| 03/07/2013 | US20130059825 Antibodies to 25-HYDROXY Vitamin D2 and D3 and Uses Thereof |
| 03/07/2013 | US20130059793 Egf receptor mimicking peptides |
| 03/07/2013 | US20130059790 Process for the preparation of a biomass comprising plantaricin and uses thereof in medical field |
| 03/07/2013 | US20130059785 Gene and Polypeptide Sequences |
| 03/07/2013 | US20130059780 Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1] |
| 03/07/2013 | US20130059752 Compositions and methods for the treatment of immune related diseases |
| 03/07/2013 | US20130059339 Apparatus and Methods for Cell Culture |
| 03/07/2013 | US20130059338 Artificial entropic bristle domain sequences and their use in recombinant protein production |
| 03/07/2013 | US20130059337 Therapeutic Uses of Humanized Antibodies Against ALPHA-4 Integrin |
| 03/07/2013 | US20130059336 Hydrophobic interaction chromatography method |
| 03/07/2013 | US20130059335 Use of a genetically modified cell line expressing functional asialoglycoprotein receptor in the production of sialylated glycoproteins |
| 03/07/2013 | US20130059334 Production of recombinant selenoprotein mutants with enhanced catalytic activity |
| 03/07/2013 | US20130059333 Hematopoietic cell selectin ligand polypeptides and methods of use thereof |
| 03/07/2013 | US20130059332 Method for the production of an aqueous glucose solution |
| 03/07/2013 | US20130059318 Anti-iga1 antibody |
| 03/07/2013 | US20130059006 3-dimensional cardiac fibroblast derived extracellular matrix |
| 03/07/2013 | US20130058955 Anti-polyubiquitin antibodies and methods of use |
| 03/07/2013 | US20130058940 Novel Gene And Protein Associated With Angiogenesis And Endothelial Cell Specific Apoptosis |
| 03/07/2013 | US20130058937 Bispecific antigen binding molecules |
| 03/07/2013 | US20130058936 Bispecific antibodies specific for t-cell activating antigens and a tumor antigen and methods of use |
| 03/07/2013 | US20130058927 Anti-vegf antibodies |
| 03/07/2013 | US20130058893 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 03/07/2013 | US20130058864 Antibodies that bind ov064 and methods of use therefor |
| 03/07/2013 | CA2847113A1 Protein production method using transformed plant cells |
| 03/07/2013 | CA2847061A1 Protein expression |
| 03/07/2013 | CA2846290A1 Engineered sequences to facilitate expression of antigens in neisseria and methods of use |
| 03/06/2013 | EP2565272A2 Fermentation medias and processes thereof |
| 03/06/2013 | EP2565269A1 High-purity soluble thrombomodulin and method for producing same |
| 03/06/2013 | EP2565268A1 Novel muc1 antibody |
| 03/06/2013 | EP2565262A1 Protein expression |
| 03/06/2013 | EP2563902A1 Improved glycosylation of proteins in host cells |
| 03/06/2013 | EP2563395A2 Anti-s1p antibody treatment of patients with ocular disease |
| 03/06/2013 | CN102959087A Compositions for linking zinc finger modules |
| 03/06/2013 | CN102952841A Method for preparing hyriopsis cumingii meat enzymolysis protein solution |
| 03/06/2013 | CN102952840A Method for rapidly improving enzymolysis effect of corn gluten meal |
| 03/06/2013 | CN102952839A Method for extracting Tuna collagen solution and product thereof |
| 03/06/2013 | CN102952838A Preparation method of immune-enhancing mussel enzymatic hydrolytic polypeptide and preparation method of corresponding tablet thereof |
| 03/06/2013 | CN102952837A Medical fish collagen polypeptide raw material and its preparation technology |
| 03/06/2013 | CN102952836A Recombinant human long-acting interleukin-1 receptor antagonist fusion protein purification method |
| 03/06/2013 | CN102952835A Method for producing cecropin by fermentation of bacillus subtilis |
| 03/06/2013 | CN102952817A Method for production of recombinant human epidermal growth factor by temperature induction |
| 03/06/2013 | CN102550794B Method for extracting cottonseed protein from cottonseed meal |
| 03/06/2013 | CN102492639B Mutant capable of raising cyclic lipopeptides antibiotic output by using RNA polymerase mutation, its preparation method and its application |